022638246	022638246	CD	B-NP	O
|	|	NN	I-NP	O
AILNH	AILNH	NN	I-NP	O
|	|	NN	I-NP	O
61626915	61626915	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5694300	5694300	CD	B-NP	O
|	|	CC	I-NP	O
3/16/2006	3/16/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
atypical	atypical	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/4/2006	6/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/7/2006	4/7/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
FINEBERG	FINEBERG	NNP	B-NP	O
,	,	,	O	O
ISMAEL	ISMAEL	NNP	B-NP	O
374-65-90-3	374-65-90-3	CD	I-NP	O
Rene	Rene	NNP	I-NP	O
Lu	Lu	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/3/06	6/3/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
URANKAR	URANKAR	NN	B-NP	O
,	,	,	O	O
RAYMOND	RAYMOND	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
3/26/06	3/26/06	CD	B-NP	O
by	by	IN	B-PP	O
DESOMMA	DESOMMA	NN	B-NP	O
,	,	,	O	O
HOWARD	HOWARD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
041292152	041292152	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
FENTANYL	FENTANYL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PATCH	PATCH	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MCG/HR	MCG/HR	NN	I-NP	O
TP	TP	NN	I-NP	O
Q72H	Q72H	NN	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q8H	Q8H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NN	I-NP	O
TERAZOSIN	TERAZOSIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
4	4	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
MIRTAZAPINE	MIRTAZAPINE	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PREVACID	PREVACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LANSOPRAZOLE	LANSOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	I-NP	O
Carbohydrate	Carbohydrate	NN	I-NP	O
Controlled	Control	VBN	B-VP	O
/	/	SYM	B-NP	B-protein
Low	Low	NN	I-NP	I-protein
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Hillenbrand	Hillenbrand	NNP	I-NP	O
6/25	6/25	CD	I-NP	O
@	@	NN	I-NP	O
1pm	1pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CP	CP	NN	B-NP	B-DNA
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
atypical	atypical	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
OTHER	OTHER	NNP	B-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
brugada	brugada	NNP	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
ICD	ICD	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	O
,	,	,	O	O
pseudodementia	pseudodementia	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
CP	CP	NN	B-NP	B-DNA
HPI	HPI	NN	I-NP	I-DNA
:	:	:	O	O
43M	43M	NN	B-NP	O
multiple	multiple	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
p/w	p/w	NN	B-NP	O
constant	constant	JJ	I-NP	O
CP	CP	NN	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
ambulating	ambulate	VBG	B-VP	O
up	up	RP	B-PRT	O
stairs	stair	NNS	B-NP	O
pt	pt	NN	I-NP	O
developed	develop	VBD	B-VP	O
sob	sob	NN	B-NP	O
with	with	IN	B-PP	O
cp	cp	NN	B-NP	B-DNA
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
left	left	JJ	B-NP	O
sided	sided	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

Associated	Associate	VBN	B-VP	O
with	with	IN	B-PP	O
sob/palp	sob/palp	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
sat	sit	VBD	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
releaved	releave	VBN	B-VP	O
with	with	IN	B-PP	O
rest	rest	NN	B-NP	O
x	x	SYM	O	O
1-2	1-2	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
SL	SL	NN	I-NP	B-protein
NTG	NTG	NN	I-NP	I-protein
given	give	VBN	B-VP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
returned	return	VBD	B-VP	O
when	when	WRB	B-ADVP	O
pt	pt	NN	B-NP	O
exercising	exercise	VBG	B-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
kids	kid	NNS	I-NP	O
,	,	,	O	O
again	again	RB	B-ADVP	O
lasting	last	VBG	B-VP	O
apporx	apporx	NN	B-NP	O
1-2	1-2	CD	B-NP	O
hrs	hr	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	NNS	I-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
up	up	RP	B-PRT	O
stairs	stair	NNS	B-NP	O
,	,	,	O	O
again	again	RB	B-NP	O
experienced	experienced	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
prompted	prompt	VBD	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
presented	present	VBN	I-VP	O
to	to	TO	B-PP	O
DMH	DMH	NN	B-NP	O
ED	ED	NN	I-NP	O
.	.	.	O	O

Per	Per	NNP	B-NP	O
pt	pt	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
heart	heart	NN	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
4	4	CD	B-NP	O
of	of	IN	B-PP	O
November	November	NNP	B-NP	O
during	during	IN	B-PP	O
ICD	ICD	NNP	B-NP	O
placement	placement	NN	I-NP	O
for	for	IN	B-PP	O
?	?	.	O	O

Brugada	Brugada	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
nonobstructive	nonobstructive	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
not	not	RB	O	O
in	in	IN	B-PP	O
NUOH	NUOH	NN	B-NP	B-protein
records	record	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Last	Last	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
with	with	IN	B-PP	O
MIBI	MIBI	NN	B-NP	B-protein
in	in	IN	B-PP	O
9/8	9/8	CD	B-NP	O
ambulated	ambulate	VBN	B-VP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
:	:	:	O	O
14	14	CD	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-protein
90	90	CD	I-NP	I-protein
PHR	PHR	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
perfussion	perfussion	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

TEE	TEE	NN	B-NP	O
2004	2004	CD	I-NP	O
-	-	HYPH	I-NP	O
EF	EF	NN	I-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
1-2	1-2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
orthopnea/PND/nocturia	orthopnea/PND/nocturia	NN	B-NP	O
,	,	,	O	O
ROS	ROS	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
f/c/cough	f/c/cough	NN	B-NP	O
/	/	SYM	B-NP	O
URI	URI	NN	I-NP	O
sx/postural	sx/postural	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

****	****	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Brugada	Brugada	NNP	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
peudodementia	peudodementia	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
/	/	SYM	I-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
,	,	,	O	O
+	+	CC	O	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
15pack	15pack	NN	I-NP	O
yrs	yr	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
LBP	LBP	NN	I-NP	O
****	****	SYM	B-NP	O
Home	Home	NNP	I-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
oxycodone	oxycodone	NN	B-NP	O
5mg	5mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
81	81	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
25mg	25mg	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
terazosin	terazosin	NN	B-NP	O
4	4	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
10	10	CD	I-NP	O
wd	wd	NN	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
1000	1000	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
enalapril	enalapril	NN	B-NP	O
5	5	CD	I-NP	O
wd	wd	NN	I-NP	O
,	,	,	O	O
prevacid	prevacid	NN	B-NP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
25	25	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
mirtazapine	mirtazapine	NN	B-NP	O
15	15	CD	I-NP	O
qd	qd	NN	I-NP	O
****	****	SYM	O	O
All	All	DT	O	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
****	****	SYM	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
Admission	Admission	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	O
80-106	80-106	CD	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
123/80	123/80	CD	I-NP	I-DNA
,	,	,	O	O
SaO2	SaO2	NN	B-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
Lungs	Lungs	NNP	I-NP	O
:	:	:	O	O
ctab	ctab	NN	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RR	RR	NN	B-NP	B-protein
,	,	,	O	O
S1S2	S1S2	NN	B-NP	O
no	no	DT	B-NP	O
m/c/g	m/c/g	NN	I-NP	O
/	/	SYM	O	O
r	r	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
reproducible	reproducible	JJ	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
palpation	palpation	NN	B-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
NABS	NABS	NNP	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
NTND	NTND	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
HSM/RT/G	HSM/RT/G	NN	I-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
WWP	WWP	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
Neuro	Neuro	NNP	I-NP	O
:	:	:	O	O
A+O	A+O	NNP	B-NP	O
x	x	NN	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
****	****	SYM	O	O
Data	Data	NNP	B-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
@	@	NN	I-NP	O
90bpm	90bpm	CD	B-NP	O
,	,	,	O	O
ST	ST	JJ	B-NP	B-protein
elevation	elevation	NN	I-NP	I-protein
V1	V1	NN	I-NP	I-protein
V2	V2	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
OLD	OLD	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversion	inversion	NN	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	B-protein
ST/T	ST/T	NN	I-NP	I-protein
wave	wave	NN	I-NP	I-protein
changes	change	NNS	I-NP	I-protein
Cardiac	Cardiac	JJ	B-NP	I-protein
Enzymes	Enzyme	NNS	I-NP	I-protein
x	x	SYM	B-NP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
negative	negative	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
2/28	2/28	CD	I-NP	O
Normal	Normal	JJ	I-NP	O
LV	LV	NN	I-NP	O
fx	fx	NN	I-NP	O
with	with	IN	B-PP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
nrl	nrl	NN	B-NP	O
RV	RV	NN	I-NP	O
fx/size	fx/size	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
RAE	RAE	NN	B-NP	B-protein
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
mildly	mildly	RB	B-VP	O
thickened	thicken	VBN	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
trace	trace	VBP	B-VP	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
structurally	structurally	RB	B-NP	O
normal	normal	JJ	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
sig	sig	NN	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
trace	trace	VBP	B-VP	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
nrl	nrl	NN	B-NP	O
pulmonic	pulmonic	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
nrl	nrl	NN	B-NP	O
aortic	aortic	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
root	root	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
main	main	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
artery	artery	NN	I-NP	O
nrl	nrl	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
,	,	,	O	O
IVC	IVC	NN	B-NP	O
nrl	nrl	NN	I-NP	O
size	size	NN	I-NP	O
with	with	IN	B-PP	O
nrl	nrl	NN	B-NP	O
RA	RA	NN	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
****	****	SYM	B-NP	O
Hospital	Hospital	NN	I-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
history	history	NN	B-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
event	event	NN	I-NP	O
thus	thus	RB	B-NP	O
pt	pt	NN	I-NP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes/serial	enzymes/serial	JJ	I-NP	I-protein
EKG	EKG	NN	I-NP	I-protein
cycles	cycle	NNS	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
negative	negative	JJ	I-NP	I-protein
x	x	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

tele	tele	NN	B-NP	O
monitoring	monitoring	NN	I-NP	O
continued	continue	VBN	B-VP	O
until	until	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
2/23	2/23	CD	B-NP	O
in	in	IN	B-PP	O
a.m.	a.m.	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
result	result	VBP	B-VP	O
as	as	IN	B-SBAR	O
above	above	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
Baseline	Baseline	NNP	I-NP	O
CV	CV	NNP	I-NP	O
meds	med	NNS	I-NP	O
continued	continue	VBD	B-VP	O
.	.	.	O	O

-LRB-	-LRB-	NNP	B-NP	O
Pt	Pt	NNP	I-NP	O
has	have	VBZ	B-VP	O
recent	recent	JJ	B-NP	O
w/u	w/u	NN	I-NP	O
with	with	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
done	done	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

EP	EP	NN	B-NP	B-protein
consulted	consult	VBD	B-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
pacer	pacer	NN	B-NP	O
-	-	HYPH	O	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
interventions	intervention	NNS	I-NP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

*	*	SYM	O	O
Pulm	Pulm	NN	B-NP	O
:	:	SYM	O	O
O2	O2	NN	B-NP	O
prn	prn	NN	I-NP	O
via	via	IN	B-PP	O
NC	NC	NNP	B-NP	O
,	,	,	O	O
BS	BS	NNP	B-NP	O
ctab	ctab	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
intervention	intervention	NN	I-NP	O
needed	need	VBD	B-VP	O
yet	yet	RB	B-NP	O
pt	pt	JJ	I-NP	O
given	give	VBN	I-NP	O
prn	prn	NN	I-NP	O
ativan	ativan	NN	I-NP	O
for	for	IN	B-PP	O
increased	increase	VBN	B-NP	O
anxiety	anxiety	NN	I-NP	O
likely	likely	RB	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
SOB	SOB	NN	B-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
Endo	Endo	NN	I-NP	O
:	:	:	O	O
known	know	VBN	B-NP	O
DMII	DMII	NN	I-NP	B-protein
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemics	hypoglycemic	NNS	I-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
held	hold	VBN	B-VP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
and	and	CC	I-NP	O
pt	pt	NN	I-NP	O
put	put	VBN	B-VP	O
on	on	IN	B-PP	O
DM	DM	NN	B-NP	O
protocol	protocol	NN	I-NP	O
with	with	IN	B-PP	O
NPH	NPH	NN	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Aspart	Aspart	NNP	B-NP	O
qac	qac	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aspart	aspart	VB	B-VP	O
SS	SS	NNP	B-NP	O
.	.	.	O	O

Carbohydrate	Carbohydrate	NN	B-NP	O
controlled	control	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
ordered	order	VBN	B-VP	O
.	.	.	O	O

A1C	A1C	NN	B-NP	O
6.5	6.5	CD	I-NP	O
.	.	.	O	O

Monitored	Monitored	NNP	B-NP	O
FSBS	FSBS	NNP	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
d/c	d/c	NN	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
baseline	baseline	NN	B-NP	O
metformin	metformin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
PPx	PPx	NN	B-NP	B-protein
:	:	SYM	I-NP	O
lovenox	lovenox	NN	I-NP	O
+	+	SYM	I-NP	O
nexium	nexium	NN	I-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow-up	Follow-up	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lathern	Lathern	JJ	B-ADJP	O
in	in	IN	B-PP	O
6/10	6/10	CD	B-NP	O
for	for	IN	B-PP	O
routine	routine	JJ	B-NP	O
pacer	pacer	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
appoinment	appoinment	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
finger	finger	NN	I-NP	O
stick	stick	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
record	record	NN	B-NP	O
for	for	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
to	to	TO	B-VP	O
adjust	adjust	VB	I-VP	O
metformin	metformin	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Return	Return	NN	B-NP	O
to	to	TO	B-PP	O
ER	ER	NN	B-NP	B-protein
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
CP/SOB/Nausea	CP/SOB/Nausea	NN	B-NP	B-protein
/	/	SYM	O	O
Vomiting	Vomit	VBG	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
VIZCAINO	VIZCAINO	NNP	B-NP	O
,	,	,	O	O
RICHARD	RICHARD	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
PA	PA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HS92	HS92	NN	I-NP	B-DNA
-RRB-	-RRB-	NN	I-NP	O
6/3/06	6/3/06	CD	I-NP	O
@	@	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
36	36	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

